Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaolai Zhou

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Hepatology (Baltimore, Md.)|March 30, 2022
ReplyJian Zhou, Shaolai Zhou, Chubin Luo
Lancet (London, England)|April 5, 2026
Perioperative immunotherapy for resectable hepatocellular carcinoma - Authors' replyFei Liang, Shaolai Zhou, Zheng Wang, et al.
Transplant Immunology|November 20, 2009
The dynamic changes of T-bet(+)/GATA-3(+) and RORgammat(+)/FOXP3(+) cells in recipient spleens and grafts after rat orthotopic liver transplantationMin Xu, Changjun Tan, Jian Zhou, et al.
Journal for Immunotherapy of Cancer|March 11, 2021
Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3Zhengjun Zhou, Pengcheng Wang, Rongqi Sun, et al.
Cancer Letters|June 30, 2024
A novel protein encoded by circFOXP1 enhances ferroptosis and inhibits tumor recurrence in intrahepatic cholangiocarcinomaPengcheng Wang, Zhiqiang Hu, Songyang Yu, et al.
Aging|June 3, 2021
Characterization of immune infiltration in sarcomatoid hepatocellular carcinomaChubin Luo, Haoyang Xin, Dan Yin, et al.
The Oncologist|April 9, 2026
Association of IDH1 Mutations with Survival and Recurrence in Resected Intrahepatic Cholangiocarcinoma Received or not Received Adjuvant ChemotherapyPengcheng Wang, Ning Li, Yuhang Ye, et al.
Oncology Reports|May 13, 2017
Novel role of semaphorin 3A in the growth and progression of hepatocellular carcinomaXuedong Li, Qing Chen, Dan Yin, et al.
Frontiers in Pharmacology|August 18, 2025
Dihydroartemisinin decreases pre-existing neutralizing antibodies against adeno-associated virus in challenged miceJingjing Fang, Enze Cui, Jinyan Xie, et al.
Hepatology (Baltimore, Md.)|February 2, 2022
Tumor-derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progressionChubin Luo, Haoyang Xin, Zhengjun Zhou, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Hepatology (Baltimore, Md.)|March 30, 2022
ReplyJian Zhou, Shaolai Zhou, Chubin Luo
Lancet (London, England)|April 5, 2026
Perioperative immunotherapy for resectable hepatocellular carcinoma - Authors' replyFei Liang, Shaolai Zhou, Zheng Wang, et al.
Transplant Immunology|November 20, 2009
The dynamic changes of T-bet(+)/GATA-3(+) and RORgammat(+)/FOXP3(+) cells in recipient spleens and grafts after rat orthotopic liver transplantationMin Xu, Changjun Tan, Jian Zhou, et al.
Journal for Immunotherapy of Cancer|March 11, 2021
Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3Zhengjun Zhou, Pengcheng Wang, Rongqi Sun, et al.
Cancer Letters|June 30, 2024
A novel protein encoded by circFOXP1 enhances ferroptosis and inhibits tumor recurrence in intrahepatic cholangiocarcinomaPengcheng Wang, Zhiqiang Hu, Songyang Yu, et al.
Aging|June 3, 2021
Characterization of immune infiltration in sarcomatoid hepatocellular carcinomaChubin Luo, Haoyang Xin, Dan Yin, et al.
The Oncologist|April 9, 2026
Association of IDH1 Mutations with Survival and Recurrence in Resected Intrahepatic Cholangiocarcinoma Received or not Received Adjuvant ChemotherapyPengcheng Wang, Ning Li, Yuhang Ye, et al.
Oncology Reports|May 13, 2017
Novel role of semaphorin 3A in the growth and progression of hepatocellular carcinomaXuedong Li, Qing Chen, Dan Yin, et al.
Frontiers in Pharmacology|August 18, 2025
Dihydroartemisinin decreases pre-existing neutralizing antibodies against adeno-associated virus in challenged miceJingjing Fang, Enze Cui, Jinyan Xie, et al.
Hepatology (Baltimore, Md.)|February 2, 2022
Tumor-derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progressionChubin Luo, Haoyang Xin, Zhengjun Zhou, et al.
Pageof 2